<?xml version="1.0" encoding="UTF-8"?>
<p>Cancer is an important cause of morbidity and mortality worldwide [
 <xref rid="B2-molecules-25-05600" ref-type="bibr">2</xref>]. The increase of the incidence indicates that 1:8 men and 1:10 women will develop this multifactorial disease in a lifetime [
 <xref rid="B2-molecules-25-05600" ref-type="bibr">2</xref>]. Due to the aforementioned, the research for alternative and complementary treatments of cancerous diseases still motivates the search for new antitumoral agents [
 <xref rid="B3-molecules-25-05600" ref-type="bibr">3</xref>]. The EOs obtained from diverse plants are able to increase the efficacy of commonly used chemotherapy drugs, having also shown pro-immune functions when administered to cancer patients [
 <xref rid="B4-molecules-25-05600" ref-type="bibr">4</xref>]. It has been reported that the EOs may interfere in various signaling pathways in cancerous cells and may exert anti-mutagenic, anti-proliferative, antioxidant and detoxifying effects [
 <xref rid="B3-molecules-25-05600" ref-type="bibr">3</xref>]. The MCF-7 line is one of the most described cell lines in the literature for testing antitumor activity of natural bioactive products. The cytotoxic effects on MCF-7 cell line treated with EOs from plants of the genus 
 <italic>Cryptocarya</italic> [
 <xref rid="B5-molecules-25-05600" ref-type="bibr">5</xref>,
 <xref rid="B6-molecules-25-05600" ref-type="bibr">6</xref>] and 
 <italic>Laurelia</italic> [
 <xref rid="B7-molecules-25-05600" ref-type="bibr">7</xref>] had previously been reported. 
</p>
